GlassScriptPhysician profile
Ramana Dutt
NPI 1801890413
$14,649.29
in general payments reported to CMS, 2019-2025
74 companies · $2,696 in 2025
The $2,696 reported for 2025 was more than what a typical Medical Oncology provider received nationally (typical 2025 total: $1,158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,386 · 2020: $1,119 · 2021: $1,207 · 2022: $1,732 · 2023: $2,624 · 2024: $2,884 · 2025: $2,696.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,198 · Education: $6.11.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,198.41 |
| Education | $6.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $1,145.23 | 2019-2025 | Opdivo, Opdualag |
| Merck Sharp & Dohme LLC | $1,011.87 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Celgene Corporation | $841.33 | 2019-2025 | Reblozyl, Opdualag |
| Astrazeneca Pharmaceuticals LP | $699.70 | 2019-2025 | Calquence, Enhertu, Imfinzi |
| Novartis Pharmaceuticals Corporation | $685.98 | 2019-2025 | |
| Pfizer INC. | $602.38 | 2019-2025 | |
| Incyte Corporation | $564.95 | 2019-2025 | Jakafi, Monjuvi, Zynyz |
| Bayer Healthcare Pharmaceuticals INC. | $536.29 | 2019-2025 | |
| Janssen Biotech, INC. | $513.59 | 2019-2025 | Rybrevant, Erleada, Imbruvica |
| Eisai INC. | $470.23 | 2019-2025 | |
| Genzyme Corporation | $446.60 | 2019-2025 | |
| Lilly USA, LLC | $438.22 | 2019-2025 | Verzenio, Jaypirca, Retevmo |
| Genentech USA, INC. | $434.68 | 2019-2025 | Tecentriq, Alecensa, Polivy |
| Astellas Pharma US INC | $343.59 | 2019-2025 | Xospata, Padcev, Xtandi |
| Gilead Sciences, INC. | $336.87 | 2019-2025 | Trodelvy |
Show all 74 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seagen INC. | $323.40 | 2019-2023 | Padcev, Tukysa, Adcetris |
| Takeda Pharmaceuticals U.S.A., INC. | $306.49 | 2019-2025 | Alunbrig, Fruzaqla |
| Daiichi Sankyo INC. | $287.80 | 2020-2025 | Enhertu, Datroway |
| Regeneron Healthcare Solutions, INC. | $283.78 | 2019-2025 | Libtayo |
| Amgen INC. | $282.33 | 2019-2023 | Kyprolis, Blincyto |
| Glaxosmithkline, LLC. | $259.31 | 2020-2025 | Ojjaara, Jemperli, Zejula |
| Array Biopharma INC | $210.02 | 2019-2025 | Braftovi, Mektovi, Tukysa |
| Csl Behring | $206.57 | 2022-2025 | Afstyla, Idelvion, Hemgenix |
| Alexion Pharmaceuticals, INC. | $193.31 | 2019-2025 | Ultomiris |
| Puma Biotechnology, INC. | $192.72 | 2021-2025 | |
| Emd Serono, INC. | $167.58 | 2019-2024 | Bavencio |
| Boehringer Ingelheim Pharmaceuticals, INC. | $164.91 | 2019-2025 | |
| G1 Therapeutics, INC. | $160.29 | 2022-2023 | Cosela |
| Abbvie INC. | $135.46 | 2019-2025 | Venclexta |
| Genmab U.S., INC. | $121.84 | 2023-2024 | Epkinly |
| Janssen Pharmaceuticals, INC | $116.35 | 2019-2024 | Xarelto |
| Aveo Pharmaceuticals, INC. | $116.34 | 2021-2025 | Fotivda |
| Jazz Pharmaceuticals INC. | $107.17 | 2021-2025 | Zepzelca |
| Pharmacosmos Therapeutics INC. | $92.72 | 2023-2025 | Monoferric, Cosela |
| Stemline Therapeutics INC. | $89.07 | 2023-2025 | Orserdu |
| Sobi, INC | $84.79 | 2023-2025 | |
| Kyowa Kirin, INC. | $82.38 | 2019-2025 | Poteligeo |
| Ipsen Biopharmaceuticals, INC | $80.82 | 2019-2025 | Somatuline Depot, Onivyde |
| Tesaro, INC. | $78.22 | 2019 | |
| Sun Pharmaceutical Industries INC. | $75.01 | 2020-2025 | Odomzo, Yonsa |
| Kite Pharma, INC. | $70.10 | 2022-2025 | Yescarta |
| Agios Pharmaceuticals, INC. | $66.85 | 2019-2025 | Pyrukynd |
| Pharmacyclics LLC, An Abbvie Company | $64.07 | 2019-2021 | |
| Rigel Pharmaceuticals, INC. | $62.65 | 2019-2024 | Rezlidhia, Tavalisse |
| Deciphera Pharmaceuticals INC. | $61.00 | 2020-2021 | |
| Legend Biotech USA INC. | $58.64 | 2025 | Carvykti |
| Beigene USA, INC. | $57.95 | 2022-2024 | Brukinsa |
| Recordati_rare_diseases_inc. | $56.56 | 2023-2025 | Enjaymo, Sylvant |
| Tempus Ai, INC | $56.29 | 2024 | Xt Cdx |
| Adc Therapeutics America, INC. | $51.64 | 2024-2025 | |
| Geron Corporation | $48.86 | 2025 | Rytelo |
| Mirati Therapeutics, INC. | $48.68 | 2023-2024 | Krazati |
| Servier Pharmaceuticals LLC | $45.74 | 2023-2024 | |
| Dova Pharmaceuticals | $41.01 | 2019-2021 | |
| Amag Pharmaceuticals, INC. | $40.34 | 2019 | |
| Sumitomo Pharma America, INC. | $39.75 | 2024-2025 | Orgovyx |
| Partner Therapeutics, INC. | $38.42 | 2019 | |
| Foundation Medicine, INC. | $38.33 | 2020 | |
| Karyopharm Therapeutics INC. | $38.12 | 2020-2023 | Xpovio |
| Aurobindo Pharma USA, INC. | $36.62 | 2019-2020 | |
| Global Blood Therapeutics, INC. | $36.43 | 2021-2022 | |
| Cti Biopharma Corp. | $35.62 | 2022-2023 | Vonjo |
| Teva Pharmaceuticals USA, INC. | $35.57 | 2019 | |
| Myovant Sciences INC. | $35.10 | 2021-2022 | |
| Beone Medicines USA, INC. | $27.01 | 2025 | Brukinsa |
| Taiho Oncology, INC. | $26.62 | 2019-2025 | |
| Fennec Pharmaceuticals, INC. | $24.11 | 2024 | Pedmark |
| Pharmaessentia USA Corporation | $22.77 | 2024 | Besremi |
| Tersera Therapeutics LLC | $19.38 | 2019 | |
| Verastem, INC. | $19.28 | 2019 | |
| Alnylam Pharmaceuticals INC. | $18.25 | 2023 | Givlaari |
| Alfasigma USA, INC. | $14.06 | 2020 | |
| Advanced Accelerator Applications | $13.38 | 2020 | |
| Veracyte, INC. | $9.90 | 2020 |
Drugs and devices associated with these payments
Keytruda $538Reblozyl $489Opdivo $414Jakafi $331Libtayo $269Sarclisa $240Lenvima $240Enhertu $217Nubeqa $193Cosela $180Padcev $179Kisqali $176Opdualag $155Pluvicto $152Tukysa $150Epkinly $142Monjuvi $140Lynparza $134Afstyla $131Idelvion $131Vitrakvi $131Stivarga $131Ultomiris $128Xofigo $128Tecentriq $127Xtandi $126Rybrevant $119Jaypirca $109Verzenio $109Trodelvy $109Alunbrig $102Braftovi $100Mektovi $100Calquence $95.72Alecensa $95.07Orserdu $89.07Bavencio $88.89Ibrance $84.56Xospata $84.00Erleada $82.36Imbruvica $79.45Fotivda $78.96Retevmo $72.92Zynyz $69.82Brukinsa $69.51Vonjo $68.69Somatuline Depot $67.75Onivyde $67.75Fruzaqla $65.22Orgovyx $64.04Lutathera $63.63Elrexfio $63.31Talzenna $63.28Venclexta $63.13Ojjaara $59.60Carvykti $58.64Adcetris $57.36Nerlynx $56.49Xt Cdx $56.29Monoferric $54.78Darzalex $53.04Promacta $51.60Ziihera $50.55Poteligeo $49.94Rytelo $48.86Krazati $48.68Pyrukynd $48.52Tavalisse $47.61Rezlidhia $47.61Tibsovo $45.74Datroway $43.87Fabhalta $43.60Polivy $42.87Scemblix $41.45Bosulif $40.76Welireg $40.05Inlyta $38.99Comirnaty $38.24Paxlovid $38.24Lorbrena $38.16Odomzo $37.23Zejula $37.05Jemperli $37.05Doptelet $34.02Hemgenix $33.85Tecvayli $33.75Elitek $33.70Enjaymo $33.45Jevtana $33.41Zynlonta $31.40Avastin $28.84Tecentriq Hybreza $27.27Zepzelca $26.62Yescarta $25.27Piqray $24.86Pedmark $24.11Sylvant $23.11Besremi $22.77Xpovio $22.49Shingrix $21.80
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ramana Dutt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.